Table 5.
Comparison characteristics between patients with and without TB-IRIS in 123 patients with HIV-TB.
| No. TB-IRIS | TB-IRIS | |
|---|---|---|
| (n = 118) | (n = 5) | |
| Age (yrs) | 37 ± 10 | 31 ± 7 |
| Sex (% male) | 80 | 80 |
| BMI (kg/m2) | 19 ± 5 | 18 ± 3 |
| ATT-ART (days) | 32 (21–70) | 20 (18–27) |
| CD4 (cells/μl) | 136 (70–225.75) | 167 (118–193) |
| Increase in CD4 | 89 (32.25–144.75) | 229 (61–283) |
| (cells/μl) | ||
| Increase in CD4 (%) | 57.6 (24–181) | 119 (63.5–207) |
| VL (log10 copies/ml) | 5.21 (4.76–5.65) | 5.49 (5.18–5.63) |
| Decrease in VL | 5.19 (4.76–5.63) | 5.49 (5.18–5.63) |
| (log10 copies/ml) | ||
| Decrease in VL (%) | 99.58 (98.85–99.9)* | 99.93 (99.91–99.97)* |
BMI: body mass index; ATT: antituberculosis treatment; ART: antiretroviral treatment; VL: viral load
Age and BMI are presented as mean ± SD; gender as % of male; EPTB as % of TB; DTB as % of EPTB and ATT-ART gap, CD4 cell counts and viral load as median and IQR
*P = .016.